Milestone Pharmaceuticals Inc. (MIST) stock

MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30

$0.66−0.01 (-1.06%)

Close on Nov 12, 2026Market cap $81.57MP/E –Yield –

Milestone Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2026	Jun 30, 2026	94.3%	–
Q1 FY2026	Mar 31, 2026	94.1%	–

See a number that looks wrong?